Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 9-amino-20(s)-camptothecin
2. 9-amino-20-camptothecin, (+-)-isomer
3. 9-amino-20-camptothecin, (r,s)-isomer
4. 9-amino-cpt
5. Nsc 603071
1. 91421-43-1
2. Aminocamptothecin
3. 9-amino-camptothecin
4. 9-amino-cpt
5. 9-amino-20(s)-camptothecin
6. 9-amino-20-(s)-camptothecin
7. Nsc-603071
8. Nsc603071
9. 5mb77ice2q
10. Chembl274070
11. (s)-10-amino-4-ethyl-4-hydroxy-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione
12. Chebi:80755
13. (s)-10-amino-4-ethyl-4-hydroxy-1h-pyrano[3',4':6,7]-indolizino[1,2-b]quinoline-3,14(4h,12h)-dione
14. Camptothecin, 9-amino-
15. (19s)-8-amino-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
16. (s)-10-amino-4-ethyl-4-hydroxy-1,12-dihydro-14h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h)-dione
17. 10-amino-4(s)-4-ethyl-4-hydroxy-1h-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4h,12h)-dione
18. 10-amino-4(s)-4-ethyl-4-hydroxy-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione
19. Mls002702905
20. Unii-5mb77ice2q
21. Nsc 603071
22. Idec-132
23. Nsc-629971
24. 9-aminocamptothecan
25. 9-amino Camptothecin
26. 9-nh2-camptothecin
27. 9-amino-2(s)-camptothecin
28. Schembl26578
29. (s)-10-amino-4-ethyl-4-hydroxy-1h-pyrano(3;,4':6,7)indolizino(1,2-b)quinoline-3,14(4h,12h)-dione
30. Cid_72402
31. Mls000728575
32. 9-aminocamptothecin [mi]
33. Dtxsid10873202
34. Hms2220k11
35. Hms3339h11
36. Hms3749c03
37. 10-amino-4-ethyl-4-hydroxy-1,12-dihydro-4h-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
38. Bcp09002
39. Ex-a4335
40. 9-amino-cpt (9-aminocamptothecin)
41. Bdbm50008936
42. Mfcd00909855
43. S2653
44. Zinc37866089
45. 9-aminocamptothecin [who-dd]
46. Akos015896595
47. Cs-7784
48. Db12515
49. Ncgc00247552-01
50. 1h-pyrano(3;,4':6,7)indolizino(1,2-b)quinoline-3,14(4h,12h)-dione, 10-amino-4-ethyl-4-hydroxy-, (s)-
51. Ac-33991
52. As-14292
53. Nci60_004578
54. Smr000445687
55. Hy-100309
56. F11420
57. 421a431
58. A843867
59. J-504140
60. Brd-k09291936-001-07-5
61. Q27149808
62. (s)-10-amino-4-ethyl-4-hydroxy-1,12-dihydro-4h-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
63. 1h-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4h,12h)-dione, 10-amino-4-ethyl-4-hydroxy-, (4s)-
64. 1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione,4-ethyl-4-hydroxy-9-nitro-
65. 1h-pyrano[3',7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione, 10-amino-4-ethyl-4-hydroxy-, (s)-
| Molecular Weight | 363.4 g/mol |
|---|---|
| Molecular Formula | C20H17N3O4 |
| XLogP3 | 0.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 1 |
| Exact Mass | 363.12190603 g/mol |
| Monoisotopic Mass | 363.12190603 g/mol |
| Topological Polar Surface Area | 106 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 775 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
ABOUT THIS PAGE
A 9-Aminocamptothecin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 9-Aminocamptothecin, including repackagers and relabelers. The FDA regulates 9-Aminocamptothecin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 9-Aminocamptothecin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 9-Aminocamptothecin supplier is an individual or a company that provides 9-Aminocamptothecin active pharmaceutical ingredient (API) or 9-Aminocamptothecin finished formulations upon request. The 9-Aminocamptothecin suppliers may include 9-Aminocamptothecin API manufacturers, exporters, distributors and traders.
click here to find a list of 9-Aminocamptothecin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 9-Aminocamptothecin DMF (Drug Master File) is a document detailing the whole manufacturing process of 9-Aminocamptothecin active pharmaceutical ingredient (API) in detail. Different forms of 9-Aminocamptothecin DMFs exist exist since differing nations have different regulations, such as 9-Aminocamptothecin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 9-Aminocamptothecin DMF submitted to regulatory agencies in the US is known as a USDMF. 9-Aminocamptothecin USDMF includes data on 9-Aminocamptothecin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 9-Aminocamptothecin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 9-Aminocamptothecin suppliers with USDMF on PharmaCompass.
9-Aminocamptothecin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 9-Aminocamptothecin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 9-Aminocamptothecin GMP manufacturer or 9-Aminocamptothecin GMP API supplier for your needs.
A 9-Aminocamptothecin CoA (Certificate of Analysis) is a formal document that attests to 9-Aminocamptothecin's compliance with 9-Aminocamptothecin specifications and serves as a tool for batch-level quality control.
9-Aminocamptothecin CoA mostly includes findings from lab analyses of a specific batch. For each 9-Aminocamptothecin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
9-Aminocamptothecin may be tested according to a variety of international standards, such as European Pharmacopoeia (9-Aminocamptothecin EP), 9-Aminocamptothecin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (9-Aminocamptothecin USP).
LOOKING FOR A SUPPLIER?
